Pet Obesity Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Pet Obesity Management Market is projected to expand from USD 11.61 Billion in 2025 to USD 17.16 Billion by 2031, registering a CAGR of 6.73%. This sector encompasses therapeutic nutritional formulations, pharmaceutical interventions, and physical rehabilitation services aimed at reducing excess body weight in companion animals. Growth is largely propelled by the increasing humanization of pets, a growing awareness of obesity-linked comorbidities like diabetes and osteoarthritis, and the need to address sedentary lifestyles through professional weight management to enhance pet longevity.

Despite these positive indicators, market expansion is hindered by a significant disconnect between actual pet health and owner perception. Many pet parents fail to identify overweight conditions accurately, resulting in delayed treatment and poor adherence to dietary restrictions. Data from the Association for Pet Obesity Prevention in 2024 reveals that only 35% of dog owners and 33% of cat owners classified their pets as overweight or obese, highlighting a gap between clinical reality and owner recognition that limits the consumer base for professional management solutions.

Market Drivers

The increasing global prevalence of pet obesity acts as the primary catalyst for market expansion, necessitating professional weight management interventions. As caloric overconsumption and sedentary behaviors become normalized, the surge in weight-related pathologies, such as metabolic dysfunction and osteoarthritis, compels veterinary professionals to implement rigorous management protocols. According to the 'Obesity Report 2024' by UK Pet Food, veterinary professionals estimate that 50% of dogs and 43% of cats in the United Kingdom are currently overweight or obese, creating a non-discretionary demand for specialized low-calorie formulations and rehabilitation services.

Concurrently, rising disposable income and dedicated pet healthcare expenditure are crucial in translating medical needs into market revenue. As pet humanization intensifies, owners show a greater willingness to invest in premium veterinary care and prescription diets to prolong their companions' lives. The American Pet Products Association's '2024-2025 National Pet Owners Survey' reported total U.S. pet industry expenditures of $147 billion in 2023, indicating a strong capacity for healthcare spending. This financial readiness supports the adoption of therapeutic solutions, with the Association for Pet Obesity Prevention reporting in May 2024 that 16% of dog owners and 25% of cat owners utilized therapeutic weight-loss diets.

Market Challenges

A fundamental restraint on the Global Pet Obesity Management Market is the substantial disparity between actual pet body condition and owner perception. This cognitive disconnect severely limits market penetration, as owners who fail to recognize weight issues are unlikely to seek pharmaceutical interventions or purchase therapeutic nutritional formulations. The inability to identify excess weight precludes necessary veterinary consultations for prescribing management solutions, thereby rendering a significant portion of the clinically addressable population inaccessible to manufacturers and suppressing demand despite the high prevalence of obesity.

Industry data underscores the magnitude of this obstacle, with UK Pet Food reporting in 2024 that while veterinary professionals classified 50% of dogs and 43% of cats as overweight or obese, 77% of owners believed their pets were at a healthy weight. This stark contrast illustrates that a vast majority of potential consumers remain unaware of their pet's medical needs, preventing the market from capitalizing on the actual volume of obesity cases. Consequently, revenue growth is impeded not by the absence of effective treatments, but by the end-user's inability to acknowledge the underlying problem.

Market Trends

The emergence of GLP-1 receptor agonist medications marks a transformative shift in the market, transitioning from traditional caloric restriction to pharmaceutical interventions comparable to human obesity treatments. These long-acting injectables leverage biological mechanisms to regulate appetite and enhance metabolic function, offering an alternative to strict dietary compliance. According to an April 2025 article by PetfoodIndustry, approximately one in three pet owners expressed willingness to use prescription weight-loss drugs for their pets if proven safe and effective, signaling a high potential for rapid adoption as owners increasingly medicalize weight management to mitigate health risks.

Simultaneously, the integration of wearable pet activity trackers is reshaping weight management strategies by offering objective data on energy expenditure to counter sedentary habits. Unlike subjective observations, these devices employ accelerometer technology to monitor activity levels and caloric burn, allowing veterinarians to design precise exercise regimens based on real-time metrics. This technology fosters a feedback loop that enhances owner engagement and adherence to rehabilitation protocols, a trend evidenced by Tractive's report in January 2025 of having over 1.3 million active subscribers utilizing their tracking solutions.

Key Players Profiled in the Pet Obesity Management Market

• Mars Incorporated
• Hill's Pet Nutrition, Inc.
• Nestle S.A
• Farmina Pet Foods Holding B.V.
• Drools Pet Food Pvt. Ltd.
• NOW Health Group, Inc.
• Virbac S.A.
• VioVet Ltd.
• Rolf C. Hagen Inc.
• Vivaldis Health & Foods Pvt. Ltd.
• Neogen Corporation

Report Scope

In this report, the Global Pet Obesity Management Market has been segmented into the following categories:

Pet Obesity Management Market, by Animal Type:

• Dogs
• Cats
• Others

Pet Obesity Management Market, by Product:

• Therapeutic Food
• Supplements

Pet Obesity Management Market, by Distribution Channel:

• Pet Specialty Stores
• E-Commerce
• Others

Pet Obesity Management Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pet Obesity Management Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.